MUSCARINIC AND DOPAMINERGIC CONTROL OF STRIATAL NEURONS
Project Number5R29NS028889-05
Contact PI/Project LeaderSURMEIER, DALTON JAMES
Awardee OrganizationUNIVERSITY OF TENNESSEE HEALTH SCI CTR
Description
Abstract Text
Parkinson's disease afflicts 1 in every 1000 adults, rising exponentially
in incidence after the age of fifty. The symptoms of this debilitating
psycho-motor illness are thought to result from a functional imbalance
between cholinergic and dopaminergic systems of the neostriatum. The
treatment of this disease has been hampered by the absence of a clear
picture of the neuromodulatory actions of these systems in the
neostriatum. Electrophysiological studies in other excitable cells have
demonstrated that acetylcholine (ACh) and dopamine (DA) exert their
effects on electrical excitability primarily by altering the properties of
voltage-dependent ionic conductances. These alterations are reflected in
the integration of synaptic input, action potential shape and spike
patterning. Previous studies of neostriatal neurons have not been able to
provide a similar level of understanding because of their reliance upon
techniques that cannot definitively characterize ionic conductances or the
molecular mechanisms mediating their modulation. In this project,
recently developed whole-cell and patch voltage-clamp techniques that
overcome these shortcomings will be used to characterize the effects of
ACh and DA on the ionic conductances of identified neostriatal neurons
dissociated from adult and juvenile rats. It is the central thesis of
this proposal that ACh and DA exert their principal effects on neostriatal
function by modulating ionic conductances and that the interaction between
these transmitters occurs at the level of the molecular events mediating
this modulation in individual neostriatal neurons. The proposed
experiments test this hypothesis in mature neostriatal neurons with
techniques capable of measuring single or multi-channel ionic currents
while controlling the biologically relevant variables: transmembrane
voltage and the biochemical composition of the intra- and extra-cellular
environment. Specifically, the proposal has three aims pertinent to a
test of this hypothesis: (1) to characterize the effects of ACh and DA on
the biophysical properties of potassium and calcium conductances in
morphologically and immunocytochemically identified postnatal rat
neostriatal neurons. Phenotypic identification of studied neurons will
focus upon axonal projections using retrograde tracing and transmitter
immunocytochemistry; (2) to characterize the role of different receptor
subtypes, GTP-binding proteins and second messenger systems in mediating
the modulatory effects of ACh and DA; and (3) to characterize the nature
of the interaction between cholinergic and dopaminergic signalling
pathways in the modulation of ionic conductances. An understanding of the
actions of ACh and DA on the electrical excitability of neostriatal
neurons should be of significance to the development of effective
therapies for Parkinson's disease. The actions of these modulators are
also of relevance to the clinical management of Huntington's disease and
the psycho-motor side-effects of neuroleptic treatment of schizophrenia.
National Institute of Neurological Disorders and Stroke
CFDA Code
DUNS Number
941884009
UEI
X1M1PN3KG3E7
Project Start Date
01-August-1990
Project End Date
31-July-1995
Budget Start Date
01-August-1994
Budget End Date
31-July-1995
Project Funding Information for 1994
Total Funding
$74,669
Direct Costs
$52,399
Indirect Costs
$22,270
Year
Funding IC
FY Total Cost by IC
1994
National Institute of Neurological Disorders and Stroke
$74,669
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R29NS028889-05
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R29NS028889-05
Patents
No Patents information available for 5R29NS028889-05
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R29NS028889-05
Clinical Studies
No Clinical Studies information available for 5R29NS028889-05
News and More
Related News Releases
No news release information available for 5R29NS028889-05
History
No Historical information available for 5R29NS028889-05
Similar Projects
No Similar Projects information available for 5R29NS028889-05